Haematology

Doç. Dr. Mesut Göçer

Doctor and researcher Antalya Şehir Hastanesi Antalya
Multiple Myeloma
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyHaematologysaglik.gov.trFrom source
  • InstitutionAntalya Şehir Hastanesisaglik.gov.trFrom source
  • Area of workMultiple MyelomaExtracted from 3 publications · Model version —From source
  • Publications27 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0002-0346-7154ORCIDFrom source
  • Last synchronised7 November 2026 00:03https://antalyasehir.saglik.gov.tr/TR-1060190/doktorlarimiz.html#mesut-gocersaglik.gov.tr

Scientific work

Publications on Multiple Myeloma

27 publications
Publications by year Most: 7, in 2020
  1. 2016: 1 publication
  2. 2017: 1 publication
  3. 2018: 0 publications
  4. 2019: 6 publications
  5. 2020: 7 publications
  6. 2021: 5 publications
  7. 2022: 2 publications
  8. 2023: 2 publications
  9. 2024: 2 publications
  10. 2025: 0 publications
  11. 2026: 1 publication

  1. Comparative efficacy and safety of G-CSF alone versus G-CSF combined with different doses of cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma

    Transfusion and Apheresis Science, 2026

    DOI 10.1016/j.transci.2026.104490 PMID 42431019 Source: ORCID

  2. Effects of Splenectomy on Natural Killer Cell Levels in β‐Thalassemia Major Patients

    Journal of Clinical Laboratory Analysis, 2024

    DOI 10.1002/jcla.25046 PMID 38814004 3 citations (Europe PMC) Open-access full textSource: ORCID

  3. The Relationship Between Ghrelin and Iron Metabolism In Beta Thalassemia Major Patients

    Archives of Medical Science, 2024

    DOI 10.5114/aoms/184702 PMID 41078927 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  4. The Relationshıp Between Ghrelin And Iron Metabolism In Beta Thassemia Major Patients

    Research Square, 2023

    DOI 10.21203/rs.3.rs-3180782/v1 Open-access full textSource: OpenAlex

  5. The Relationship Between Ghrelin and Iron Metabolism in Beta Thassemia Major Patients

    Research Square, 2023

    DOI 10.21203/rs.3.rs-3163185/v1 Open-access full textSource: OpenAlex

  6. Turkey Real-Life Data: Demographic Features, Treatment Results and Effects of Comorbidities in Chronic Myeloid Leukemia

    International Journal of Hematologic Oncology, 2022

    DOI 10.2217/ijh-2021-0008 PMID 36101779 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  7. IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY

    Mediterranean Journal of Hematology and Infectious Diseases, 2022

    DOI 10.4084/mjhid.2022.074 PMID 36425152 6 citations (Europe PMC) Open-access full textSource: ORCID

  8. Prognostic significance of hematogone presence after autologous stem cell transplantation in patients with multiple myeloma

    Cytometry Part B: Clinical Cytometry, 2021

    DOI 10.1002/cyto.b.22003 PMID 33905180 1 citation (Europe PMC) Open-access full textSource: ORCID

  9. Effect of prophylactic leukapheresis on early mortality and overall survival in acute leukemia patients with hyperleukocytosis

    Therapeutic Apheresis and Dialysis, 2021

    DOI 10.1111/1744-9987.13645 PMID 33686785 7 citations (Europe PMC) Source: ORCID

  10. Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?

    Journal of Clinical Apheresis, 2021

    DOI 10.1002/jca.21864 PMID 33333593 2 citations (Europe PMC) Source: ORCID

View all 27 publications